ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $73,213,635.57

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$161.67

▼ -0.61 (-0.38%)

As of 04/15/2024 01:00 AM ET

Days: 30 | 90 | 365

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00
11/2/2021	Roxanne S. Austin	Director	Sell	51,844	$116.38	$6,033,604.72
8/23/2021	Carrie C. Strom	SVP	Sell	5,057	$120.00	$606,840.00	11,595
5/3/2021	Carrie C. Strom	SVP	Sell	4,184	$112.40	$470,281.60	63,409

A.I. “Perfect Storm” Could Send THESE Stocks Sky High

From InvestorPlace | Ad

A little-known investment analyst whose performance beat out 15,000+ other experts in 2020 has identified an opportunity in the A.I. space. He's calling it A.I.'s perfect storm.

>>Check out what this A.I. Perfect Storm is<<

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2024	Procyon Advisors LLC	28,076	$5.11M	0.4%	-7.0%	0.002%
4/16/2024	First National Bank Sioux Falls	6,113	$1.11M	0.6%	-1.6%	0.000%
4/16/2024	Viking Fund Management LLC	133,250	$24.27M	4.4%	-6.3%	0.008%
4/16/2024	PFS Partners LLC	1,217	$0.22M	0.1%	+9.2%	0.000%
4/16/2024	Mosley Wealth Management	3,828	$0.70M	0.7%	-2.0%	0.000%
4/16/2024	Franklin Street Advisors Inc. NC	188,795	$34.38M	2.5%	-1.5%	0.011%
4/15/2024	Janiczek Wealth Management LLC	1,765	$0.32M	0.1%	-20.9%	0.000%
4/15/2024	Exeter Financial LLC	21,788	$3.66M	1.7%	-0.9%	0.001%
4/15/2024	Investment Partners Asset Management Inc.	2,285	$0.42M	0.4%	+9.5%	0.000%
4/15/2024	Agate Pass Investment Management LLC	59,972	$10.92M	5.9%	+6.0%	0.003%
4/15/2024	Signet Financial Management LLC	42,664	$7.77M	1.1%	+0.3%	0.002%
4/15/2024	Sage Investment Advisers LLC	1,126	$0.21M	0.2%	-29.0%	0.000%
4/15/2024	Epiq Partners LLC	3,753	$0.68M	0.5%	-78.7%	0.000%
4/15/2024	Wealthcare Advisory Partners LLC	42,837	$7.80M	0.3%	+23.6%	0.002%
4/15/2024	Corundum Group Inc.	4,866	$0.89M	0.4%	-2.1%	0.000%
4/15/2024	DGS Capital Management LLC	3,279	$0.60M	0.2%	+33.0%	0.000%
4/15/2024	Peterson Wealth Advisors LLC	3,979	$0.73M	0.2%	-11.1%	0.000%
4/15/2024	Revolve Wealth Partners LLC	3,083	$0.56M	0.1%	+10.1%	0.000%
4/15/2024	Matrix Asset Advisors Inc. NY	142,956	$26.03M	3.1%	-13.1%	0.008%
4/15/2024	Aspiriant LLC	9,265	$1.69M	0.1%	+2.9%	0.001%
4/15/2024	St. Johns Investment Management Company LLC	4,008	$0.73M	0.4%	+18.4%	0.000%
4/15/2024	G&S Capital LLC	5,838	$1.06M	0.5%	-1.4%	0.000%
4/15/2024	Aletheian Wealth Advisors LLC	1,609	$0.29M	0.2%	+18.0%	0.000%
4/15/2024	Key Client Fiduciary Advisors LLC	14,488	$2.64M	1.4%	-5.6%	0.001%
4/15/2024	GoalVest Advisory LLC	14,857	$2.71M	0.9%	+121.8%	0.001%
4/15/2024	Sunpointe LLC	3,139	$0.57M	0.6%	-16.7%	0.000%
4/15/2024	Sovereign Financial Group Inc.	3,212	$0.59M	0.2%	+18.6%	0.000%
4/15/2024	Future Financial Wealth Managment LLC	6,709	$1.22M	0.9%	-3.8%	0.000%
4/15/2024	AHL Investment Management Inc.	22,438	$4.09M	3.1%	-2.3%	0.001%
4/15/2024	Whitcomb & Hess Inc.	1,900	$0.35M	0.1%	-23.4%	0.000%
4/15/2024	Brookstone Capital Management	83,013	$15.12M	0.3%	+3.8%	0.005%
4/15/2024	RMR Wealth Builders	12,010	$2.19M	0.3%	+11.4%	0.001%
4/15/2024	Elevated Capital Advisors LLC	18,705	$3.41M	1.0%	+1.8%	0.001%
4/15/2024	Sunbelt Securities Inc.	46,398	$8.45M	0.9%	-8.3%	0.003%
4/15/2024	Atlas Capital Advisors LLC	1,406	$0.26M	0.0%	-80.2%	0.000%
4/15/2024	Eagle Wealth Strategies LLC	2,352	$0.43M	0.3%	-4.0%	0.000%
4/15/2024	CIC Wealth LLC	6,797	$1.24M	0.4%	+15.7%	0.000%
4/15/2024	Chemistry Wealth Management LLC	20,460	$3.73M	1.0%	-1.2%	0.001%
4/15/2024	CFM Wealth Partners LLC	20,264	$3.69M	0.7%	+5.0%	0.001%
4/15/2024	Windsor Capital Management LLC	2,425	$0.44M	0.1%	+5.0%	0.000%
4/15/2024	Kingswood Wealth Advisors LLC	19,232	$3.50M	0.4%	+1.4%	0.001%
4/15/2024	Mcdonald Partners LLC	23,377	$4.26M	1.2%	+4.0%	0.001%
4/15/2024	Sound Income Strategies LLC	102,264	$18.62M	1.4%	+9.8%	0.006%
4/15/2024	West Paces Advisors Inc.	9,847	$1.79M	0.5%	-3.0%	0.001%
4/15/2024	Kwmg LLC	1,244	$0.23M	0.0%	N/A	0.000%
4/15/2024	Security National Bank	2,014	$0.37M	0.1%	-26.2%	0.000%
4/15/2024	Prentice Wealth Management LLC	6,064	$1.10M	0.4%	+3.6%	0.000%
4/15/2024	Thompson Investment Management Inc.	38,941	$7.09M	1.1%	-0.9%	0.002%
4/15/2024	Etesian Wealth Advisors Inc.	10,060	$1.83M	1.1%	-9.7%	0.001%
4/13/2024	First Financial Corp IN	11,078	$2.02M	1.0%	-31.8%	0.001%
4/13/2024	Hoxton Planning & Management LLC	1,537	$0.28M	0.1%	+11.8%	0.000%
4/13/2024	Columbus Macro LLC	14,195	$2.59M	1.0%	-6.9%	0.001%
4/13/2024	New England Professional Planning Group Inc.	1,254	$0.23M	0.1%	N/A	0.000%
4/13/2024	Priebe Wealth Holdings LLC	2,218	$0.40M	0.3%	-13.1%	0.000%
4/13/2024	Inspirion Wealth Advisors LLC	208,766	$38.02M	6.3%	-0.8%	0.012%
4/13/2024	Community Bank of Raymore	22,648	$4.12M	1.9%	+2.7%	0.001%
4/13/2024	Evanson Asset Management LLC	3,701	$0.67M	0.1%	-4.3%	0.000%
4/13/2024	Wallace Advisory Group LLC	3,080	$0.56M	0.4%	-3.4%	0.000%
4/12/2024	Dynamic Advisor Solutions LLC	64,784	$11.80M	0.4%	-3.4%	0.004%
4/12/2024	Fermata Advisors LLC	1,469	$0.27M	0.1%	-12.1%	0.000%
4/12/2024	West Coast Financial LLC	1,578	$0.29M	0.0%	+9.7%	0.000%
4/12/2024	Mechanics Bank Trust Department	10,031	$1.83M	0.3%	-11.2%	0.001%
4/12/2024	Gilman Hill Asset Management LLC	15,849	$2.89M	0.5%	-3.1%	0.001%
4/12/2024	Annex Advisory Services LLC	63,876	$11.63M	0.4%	-2.0%	0.004%
4/12/2024	Gateway Investment Advisers LLC	441,452	$80.39M	0.9%	-7.0%	0.025%
4/12/2024	Jacobs & Co. CA	61,196	$11.14M	1.2%	-2.8%	0.003%
4/12/2024	Keystone Wealth Services LLC	5,573	$1.02M	0.3%	-3.7%	0.000%
4/12/2024	Morton Capital Management LLC CA	9,385	$1.71M	0.5%	-2.7%	0.001%
4/12/2024	Wealth Management Partners LLC	4,341	$0.79M	0.4%	-7.7%	0.000%
4/12/2024	Charles Schwab Trust Co	20,585	$3.75M	0.4%	-18.0%	0.001%
4/12/2024	Capital Advisors Wealth Management LLC	10,296	$1.88M	0.4%	-26.3%	0.001%
4/12/2024	Strong Tower Advisory Services	6,436	$1.16M	0.5%	+13.9%	0.000%
4/12/2024	Austin Private Wealth LLC	4,005	$0.71M	0.1%	+6.6%	0.000%
4/12/2024	Strategic Planning Group LLC	24,788	$4.51M	1.1%	+14.2%	0.001%
4/12/2024	CGN Advisors LLC	1,801	$0.33M	0.0%	-22.1%	0.000%
4/12/2024	Allen Mooney & Barnes Investment Advisors LLC	86,767	$14.54M	2.8%	-1.3%	0.005%
4/12/2024	Kaydan Wealth Management Inc.	1,138	$0.21M	0.1%	N/A	0.000%
4/12/2024	Capital Planning LLC	6,084	$1.11M	0.4%	+18.1%	0.000%
4/12/2024	Perkins Coie Trust Co	23,636	$4.30M	1.0%	-3.4%	0.001%
4/12/2024	Miller Howard Investments Inc. NY	456,849	$83.19M	2.7%	-1.4%	0.026%
4/12/2024	Harbor Investment Advisory LLC	20,783	$3.79M	0.4%	+0.7%	0.001%
4/12/2024	Financial Synergies Wealth Advisors Inc.	386	$70K	0.0%	+177.7%	0.000%
4/12/2024	Global Assets Advisory LLC	873,418	$159.05M	0.5%	N/A	0.049%
4/12/2024	Southland Equity Partners LLC	7,677	$1.40M	0.4%	+23.9%	0.000%
4/12/2024	Range Financial Group LLC	14,162	$2.58M	1.3%	+1.8%	0.001%
4/12/2024	Lloyd Advisory Services LLC.	8,550	$1.56M	0.3%	+377.1%	0.000%
4/12/2024	AdvisorNet Financial Inc	4,524	$0.82M	0.1%	+28.4%	0.000%
4/12/2024	CHICAGO TRUST Co NA	65,194	$11.87M	2.5%	+1.3%	0.004%
4/12/2024	Baker Boyer National Bank	1,684	$0.31M	0.1%	-11.1%	0.000%
4/12/2024	Northwest Investment Counselors LLC	1,031	$0.19M	0.0%	N/A	0.000%
4/12/2024	FCF Advisors LLC	63,965	$11.65M	2.9%	+8.6%	0.004%
4/12/2024	Cherrydale Wealth Management LLC	1,436	$0.26M	0.1%	N/A	0.000%
4/12/2024	True North Advisors LLC	6,629	$1.21M	0.3%	+1.8%	0.000%
4/12/2024	Abacus Planning Group Inc.	1,408	$0.26M	0.1%	-25.2%	0.000%
4/12/2024	Anderson Hoagland & Co.	2,651	$0.45M	0.1%	+8.9%	0.000%
4/12/2024	High Net Worth Advisory Group LLC	46,573	$8.48M	2.7%	+5.9%	0.003%
4/11/2024	City Holding Co.	40,334	$7.35M	1.1%	+1.1%	0.002%
4/11/2024	Fort Pitt Capital Group LLC	4,540	$0.83M	0.0%	-6.3%	0.000%
4/11/2024	Ballentine Partners LLC	31,279	$5.70M	0.1%	+23.5%	0.002%
4/11/2024	San Luis Wealth Advisors LLC	1,418	$0.26M	0.1%	-6.6%	0.000%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $161.67

$161.50

$164.70

50 Day Range

MA: $176.23

$161.67

$182.10

52 Week Range

Now: $161.67

$130.96

$182.89

Volume

5,433,195 shs

Average Volume

5,416,790 shs

Market Capitalization

$286.26 billion

P/E Ratio

59.22

Dividend Yield

3.82%

Beta

0.58

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Azita Saleki-Gerhardt (EVP)
Michael Severino (Vice Chairman)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Henry O Gosebruch (EVP)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
Guinness Asset Management LTD — 0.07%
Global Assets Advisory LLC — 0.05%
Ferguson Wellman Capital Management Inc. — 0.04%
Miller Howard Investments Inc. NY — 0.03%
Gateway Investment Advisers LLC — 0.02%
Welch Group LLC — 0.02%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Los Angeles Capital Management LLC
Portman Square Capital LLP
Gateway Investment Advisers LLC
Matrix Asset Advisors Inc. NY
Massmutual Trust Co. FSB ADV
Guinness Asset Management LTD
Epiq Partners LLC
Mather Group LLC.
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Azita Saleki-Gerhardt (EVP)
Michael Severino (Vice Chairman)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
Global Assets Advisory LLC
Ferguson Wellman Capital Management Inc.
BTC Capital Management Inc.
First Financial Bank Trust Division
D. Scott Neal Inc.
Investment Partners LTD.
Sound Income Strategies LLC
Wealthcare Advisory Partners LLC